Randomized, Prospective Comparison of the Outcome of Toric Implantable Contact Lens (TICL) and Q-LASIK for the Correction of Myopia With Astigmatism

Randomized, Prospective Comparison of the Outcome of TICL and Q Value Customized LASIK for the Correction of Myopia With Astigmatism

The objective is to conduct a contralateral prospective clinical study to compare the safety, efficacy, and quality of vision of the STAAR Surgical Co. Toric Implantable Contact Lens TICL) versus Custom Laser Vision Correction (Q-LASIK) in human eyes for the correction of myopia with astigmatism.

Inclusion Criteria:

• Age: 21-45 years old
• Documented stable refraction for at least 1 year
• (-3.0 to -8.0D of myopia with -1.0 to -4.0D of astigmatism or SE from -3.5 to -10D
• BSCVA: 20/20 or better
• Pupil diameter: smaller than 7mm under mesopic condition
• Contact lens discontinued 3 weeks and 1 week for hard and soft wearers respectively

Exclusion Criteria:

• Evidence of progressive or acute disease
• Evidence of connective tissue disease or clinically significant atopic disease
• ACD less than 2.8mm from endothelium
• ECC less than 2200 cells/mm2
• Narrow angle of anterior chamber
• Residual stromal thickness less than 280 microns